
Clinical UpdatesCost-Effectivenessfirst trimester screening
First Trimester Screening for Preterm Preeclampsia in the United Kingdom: Evaluating the Cost-Effectiveness of the FMF Strategy versus NICE Guidelines
By MedXY|Jul 4, 2026
This review synthesizes evidence on the cost-effectiveness of the FMF first-trimester screening strategy for preterm preeclampsia in the UK compared to NICE recommendations, highlighting clinical efficacy, economic benefits, and implication